YU42796A - Farmacetuski preparat koji sadrži ipriflavon, podesan za smanjenje broja cd8+ćelija - Google Patents

Farmacetuski preparat koji sadrži ipriflavon, podesan za smanjenje broja cd8+ćelija

Info

Publication number
YU42796A
YU42796A YU42796A YU42796A YU42796A YU 42796 A YU42796 A YU 42796A YU 42796 A YU42796 A YU 42796A YU 42796 A YU42796 A YU 42796A YU 42796 A YU42796 A YU 42796A
Authority
YU
Yugoslavia
Prior art keywords
phrimacetic
ipriflavon
adjustable
product contained
cell reduction
Prior art date
Application number
YU42796A
Other languages
English (en)
Serbo-Croatian (sh)
Inventor
Attila Kovacs
Peter Aranyi
Tereezia Kerepesi
Attila Tar
Original Assignee
Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. filed Critical Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt.
Publication of YU42796A publication Critical patent/YU42796A/sh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Saccharide Compounds (AREA)
YU42796A 1995-07-21 1996-07-19 Farmacetuski preparat koji sadrži ipriflavon, podesan za smanjenje broja cd8+ćelija YU42796A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9502198A HU9502198D0 (en) 1995-07-21 1995-07-21 Novel indication

Publications (1)

Publication Number Publication Date
YU42796A true YU42796A (sh) 1999-03-04

Family

ID=10987063

Family Applications (1)

Application Number Title Priority Date Filing Date
YU42796A YU42796A (sh) 1995-07-21 1996-07-19 Farmacetuski preparat koji sadrži ipriflavon, podesan za smanjenje broja cd8+ćelija

Country Status (22)

Country Link
EP (1) EP0841915A1 (cs)
JP (1) JP2001503371A (cs)
KR (1) KR19990028933A (cs)
CN (1) CN1191483A (cs)
AR (1) AR002905A1 (cs)
AU (1) AU6367096A (cs)
BG (1) BG102182A (cs)
BR (1) BR9610187A (cs)
CA (1) CA2227421A1 (cs)
CZ (1) CZ2798A3 (cs)
EA (1) EA199800146A1 (cs)
EE (1) EE9800020A (cs)
HR (1) HRP960345A2 (cs)
HU (1) HU9502198D0 (cs)
IL (1) IL122751A0 (cs)
MX (1) MX9800603A (cs)
NO (1) NO980127D0 (cs)
PL (1) PL324460A1 (cs)
SK (1) SK3298A3 (cs)
WO (1) WO1997003664A1 (cs)
YU (1) YU42796A (cs)
ZA (1) ZA966079B (cs)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1241079B (it) * 1990-03-23 1993-12-29 Chiesi Farma Spa Composizioni farmaceutiche contenenti ipriflavone,procedimento per la loro preparazione e relativo impiego terapeutico
HU212932B (en) * 1993-08-02 1996-12-30 Chinoin Gyogyszer Es Vegyeszet Parmaceutical composition containing ipriflavone, hydroxyapatit and tricalciumphosphate for treating lack of bones and process for producing the composition

Also Published As

Publication number Publication date
MX9800603A (es) 1998-04-30
SK3298A3 (en) 1998-07-08
AU6367096A (en) 1997-02-18
CZ2798A3 (cs) 1998-06-17
NO980127L (no) 1998-01-12
WO1997003664A1 (en) 1997-02-06
EE9800020A (et) 1998-08-17
HU9502198D0 (en) 1995-09-28
AR002905A1 (es) 1998-04-29
BG102182A (bg) 1998-08-31
EP0841915A1 (en) 1998-05-20
PL324460A1 (en) 1998-05-25
CN1191483A (zh) 1998-08-26
CA2227421A1 (en) 1997-02-06
IL122751A0 (en) 1998-08-16
HRP960345A2 (en) 1998-02-28
JP2001503371A (ja) 2001-03-13
ZA966079B (en) 1998-01-19
NO980127D0 (no) 1998-01-12
BR9610187A (pt) 1998-07-28
KR19990028933A (ko) 1999-04-15
WO1997003664A8 (en) 1999-08-05
EA199800146A1 (ru) 1998-08-27

Similar Documents

Publication Publication Date Title
UA41989C2 (uk) Фармацевтична композиція у вигляді гелю для лікування захворювань шкіри та спосіб лікування інфікованої шкіри
MX9702932A (es) L-ribofuranosilnucleosidos.
MY107341A (en) Novel hydroxamic acid and n-hydroxyurea derivatives and their use
DE60040753D1 (de) Therapeutische verwendungen von steroiden bei blutzellmangelzustaenden
MX9307509A (es) Metodo y preparacion farmaceutica para reducir la actividad de las celulas.
DE69526353D1 (de) Immunologische aktivität der rhamnolipide
DK284386A (da) Farmaceutisk praeparat mod hudlidelser
IT1170214B (it) Composizione farmaceutica per la cura delle arteriopatie periferiche
ATE218868T1 (de) Hustenhemmende, theobromine enthaltende zusammensetzungen
EP0959889A4 (en) METHOD AND COMPOSITIONS FOR INHIBITING PROLIFERATION OF KERATINOCYTE
DE69632396D1 (de) Behandlung von erkrankungen, die vom cytokinwachstumsfaktor verursacht werden
GB2210789A (en) Topical application for skin care
MX9702926A (es) L-eritrosilnucleosidos.
KR101563322B1 (ko) 피부 온도 감응형 기능성 하이드로 겔을 이용한 목 패치 및 그 제조방법
YU42796A (sh) Farmacetuski preparat koji sadrži ipriflavon, podesan za smanjenje broja cd8+ćelija
DE69919597D1 (de) Topische formulierungen, die hautpenetrations-mittel enthalten, und ihre verwendung
KR880007068A (ko) 13-시스 레티노산의 용도
FR2867476B1 (fr) Derives de genkwanine et sakuranetine, utilisation cosmetique et therapeutique, et procede de preparation
JPH08337510A (ja) メラニン生成抑制剤
ATE245998T1 (de) Somatostatin agoniste zur reduzierung von körpergewicht
JP2001261567A (ja) 皮膚外用剤
HRP20060040A2 (hr) ČISTI d-(17α)-13-ETIL-17-HIDROKSI-18,19-DINORPREGN-4-EN-20-IN-3-ON-3E I -3Z-OKSIM IZOMERI, KAOI POSTUPAK ZA SINTEZU SMJESE IZOMERA I ČISTIH IZOMERA
RU94033851A (ru) Вещество, стимулирующее функциональную активность наружных тканей организма
WO1988007371A3 (en) Prevention and treatment of the deleterious effects of exposing skin to the sun, and compositions therefor
FR2592302A1 (fr) Compositions cosmetiques pour le traitement de la peau et des cheveux gras, a base de di(beta-hydroxyethyl) sulfoxyde, et leur application.